219
Views
6
CrossRef citations to date
0
Altmetric
Case Report

Fungicidal activity and PK/PD of caspofungin as tools to guide antifungal therapy in a fluconazole-resistant C. parapsilosis candidemia

, , ORCID Icon, , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tamás Kardos, Renátó Kovács, Gábor Kardos, Istvan Varga, Aliz Bozó, Zoltán Tóth, Fruzsina Nagy & László Majoros. (2018) Poor in vivo efficacy of caspofungin, micafungin and amphotericin B against wild-type Candida krusei clinical isolates does not correlate with in vitro susceptibility results. Journal of Chemotherapy 30:4, pages 233-239.
Read now

Articles from other publishers (5)

Nerea Jauregizar, Guillermo Quindós, Sandra Gil-Alonso, Elena Suárez, Elena Sevillano & Elena Eraso. (2022) Postantifungal Effect of Antifungal Drugs against Candida: What Do We Know and How Can We Apply This Knowledge in the Clinical Setting?. Journal of Fungi 8:7, pages 727.
Crossref
Nicolas Garbez, Litaty C. Mbatchi, Steven C. Wallis, Laurent Muller, Jeffrey Lipman, Jason A. Roberts, Jean-Yves Lefrant & Claire Roger. (2021) Caspofungin Population Pharmacokinetic Analysis in Plasma and Peritoneal Fluid in Septic Patients with Intra-Abdominal Infections: A Prospective Cohort Study. Clinical Pharmacokinetics 61:5, pages 673-686.
Crossref
Benjamin KablyManon LaunayAudrey DerobertmasureSandrine Lefeuvre, Eric DannaouiEliane M. Billaud. (2022) Antifungal Drugs TDM: Trends and Update. Therapeutic Drug Monitoring 44:1, pages 166-197.
Crossref
Sébastien Bailly, Elodie Gautier-Veyret, Minh P. Lê, Lila Bouadma, Olivier Andremont, Mathilde Neuville, Bruno Mourvillier, Romain Sonneville, Eric Magalhaes, Jordane Lebut, Aguila Radjou, Roland Smonig, Michel Wolff, Laurent Massias, Claire Dupuis & Jean-François Timsit. (2020) Impact of Loading Dose of Caspofungin in Pharmacokinetic-Pharmacodynamic Target Attainment for Severe Candidiasis Infections in Patients in Intensive Care Units: the CASPOLOAD Study. Antimicrobial Agents and Chemotherapy 64:12.
Crossref
. (2017) Amphotericin-B liposomal/fluconazole. Reactions Weekly 1682:1, pages 31-31.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.